Farmington Hills, MI, January 16, 2020 –E.M.M.A. International Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting for the Biotechnology, Pharmaceuticals, and Medical Device industries, is pleased to announce new members to their Advisory Board, comprised of representatives from the industry and partner companies with leading expertise in areas relevant to the mission of EMMA International. The Advisory Board will assist EMMA International in expanding and improving its overall business strategy and enhancing marketing and external affairs.
With a wide range of skills and experiences as leaders in their fields, the members of the Advisory Board will work closely with the firm’s leadership team to address the growing needs of the market place, and plan for future strategic and regional growth.
The Advisory Board members are:
- Neil Chapman, President, Impact Analytical
- Jan Flegeau, Associate Director of Regulatory Affairs at Johnson & Johnson
- Daniel Medrano, Corporate Vice President at McLaren Health Care
- Fred Molnar, Vice President of Entrepreneur and Innovation at the Michigan Economic Development Corporation (MEDC)
- Stephen T. Rapundalo, PhD, President & CEO of MichBio
“I am delighted to work with such an accomplished group of seasoned professionals. EMMA International is grateful for their support, input and expertise to enable us to keep our finger on the pulse of the industry, said Dr. Carmine Jabri, President of EMMA International. The insight, contribution, and involvement of the Advisory Board will prove to be invaluable to the firm, its leadership team, and all stakeholders involved. The members of the Advisory Board, through their expertise, accomplishments, and astounding reputation, will help EMMA International in its current and future strategic direction.”
